findmyKOL

Pooneh Alborzi, MD

Basic profile

Penn Center for AIDS Research

ORCIDNone on fileNPI
RegionPhiladelphia, PA · NortheastSpecialtyNephrologyFocusNephrology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2020Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Pooneh Alborzi is a Nephrology physician affiliated with Penn Center for AIDS Research. OpenAlex indexes 7 publications with 1,064 citations (h-index 6).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
7publications

Distinct works indexed by OpenAlex.

1,064citations

Total citations across indexed works.

6h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
9companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

700 Spruce St Ste 403
Philadelphia, PA 191064027

Telephone

215-829-8420

Provider last certified this registry record 6 Nov 2025.

View the NPPES registry record

Industry payments

9 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    47.9%
    Calcium channel blocker19.9%
    Amlodipine Besylate78%Nifedipine Er22%
    Part D<11 patients
    Angiotensin receptor blocker (ARB)10.4%
    Losartan Potassium100%
    Part D17 patients

    + 4 more classes in this area

  • Metabolism & gastrointestinal

    21.6%
    SGLT2 inhibitor11.7%
    Jardiance68%Farxiga32%
    Part D<11 patients
    Vitamin D3 Analog5.5%
    Calcitriol100%
    Part D<11 patients

    + 1 more class in this area

  • Other

    19.9%
    Phosphate Binder10.6%
    Sevelamer Carbonate100%
    Part D<11 patients
    Drugs for treatment of hyperkalemia and hyperphosphatemia9.3%
    Lokelma100%
    Part D11 patients
Where care is delivered (Part B)63.3% facility · 36.7% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”